Reaction
Angioplasty reporting signals
As of the last recalculation, Angioplasty appears in 1,477 FAERS reports alongside 38 co-occurring drug terms. The strongest observed disproportionality signal is RANOLAZINE (PRR 48.4).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Ranolazine | 35 | 48.4 | 48.5 |
| Riociguat | 62 | 27.9 | 28.0 |
| Ciclesonide | 20 | 21.0 | 21.0 |
| Prasugrel Hydrochloride | 14 | 19.6 | 19.6 |
| Etonogestrel And Ethinyl Estradiol | 27 | 17.5 | 17.5 |
| Ezetimibe And Simvastatin | 18 | 16.9 | 16.9 |
| Nitroglycerin | 58 | 15.8 | 15.8 |
| Valsartan And Hydrochlorothiazide | 15 | 15.7 | 15.7 |
| Clopidogrel | 184 | 14.8 | 14.8 |
| Macitentan | 64 | 13.6 | 13.6 |
| Captopril | 9 | 13.3 | 13.3 |
| Clopidogrel Bisulfate | 86 | 12.5 | 12.5 |
| Bosentan | 41 | 11.8 | 11.8 |
| Sevelamer Carbonate | 9 | 11.1 | 11.1 |
| Losartan Potassium And Hydrochlorothiazide | 8 | 9.8 | 9.8 |
| Epoprostenol | 9 | 9.7 | 9.7 |
| Isosorbide Mononitrate | 14 | 9.6 | 9.6 |
| Isosorbide Dinitrate | 13 | 9.5 | 9.5 |
| Selexipag | 17 | 9.4 | 9.4 |
| Human Insulin | 8 | 9.1 | 9.1 |
| Ticagrelor | 20 | 8.9 | 8.9 |
| Amiodarone Hydrochloride | 7 | 8.8 | 8.8 |
| Sildenafil Powder, | 22 | 8.8 | 8.8 |
| Clobetasol Propionate Ointment Usp, 0.05% | 6 | 8.2 | 8.2 |
| Clobetasol Propionate | 6 | 8.2 | 8.2 |
| Latanoprost | 28 | 8.0 | 8.0 |
| Desoximetasone | 10 | 7.4 | 7.4 |
| Sitagliptin And Metformin Hydrochloride | 11 | 7.2 | 7.2 |
| Pitavastatin Calcium | 5 | 6.9 | 6.9 |
| Metformin Hcl | 26 | 6.7 | 6.7 |
| Mepolizumab | 22 | 6.3 | 6.3 |
| Paricalcitol | 6 | 6.0 | 6.0 |
| Ixekizumab | 12 | 4.6 | 4.6 |
| Ambrisentan | 35 | 4.0 | 4.0 |
| Alirocumab | 6 | 3.4 | 3.4 |
| Relugolix | 5 | 3.0 | 3.0 |
| Bimekizumab | 4 | 2.7 | 2.7 |
| Evolocumab | 18 | 1.6 | 1.6 |